Detalles de la búsqueda
1.
HBV DNA and HBsAg Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and HBsAg Loss in HBeAg-Negative Patients Who Discontinued Antiviral Therapy.
Gastroenterology
; 166(1): 168-177.e8, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37769952
2.
NMR-based metabolomic signature: An important tool for the diagnosis and study of pathogenesis of autoimmune hepatitis.
Hepatology
; 2024 Feb 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38305739
3.
Lack of complete biochemical response in autoimmune hepatitis leads to adverse outcome: First report of the IAIHG retrospective registry.
Hepatology
; 79(3): 538-550, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37676683
4.
Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain?
Hepatology
; 79(1): 39-48, 2024 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37399238
5.
PAGE-B incorporating moderate HBV DNA levels predicts risk of HCC among patients entering into HBeAg-positive chronic hepatitis B.
J Hepatol
; 80(1): 20-30, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37734683
6.
Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis.
J Hepatol
; 80(1): 53-61, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37802188
7.
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.
Hepatology
; 78(2): 397-415, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37386786
8.
Transitions of blood immune endotypes and improved outcome by anakinra in COVID-19 pneumonia: an analysis of the SAVE-MORE randomized controlled trial.
Crit Care
; 28(1): 73, 2024 03 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38475786
9.
Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls.
Gastroenterology
; 163(6): 1630-1642.e3, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36150526
10.
Ursodeoxycholic Acid Treatment-Induced GLOBE Score Changes Are Associated With Liver Transplantation-Free Survival in Patients With Primary Biliary Cholangitis.
Am J Gastroenterol
; 118(7): 1196-1203, 2023 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36621963
11.
Hepatic safety and efficacy of immunomodulatory drugs used in patients with autoimmune hepatitis.
J Autoimmun
; 140: 103113, 2023 Sep 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37716078
12.
Quantification of polyreactive immunoglobulin G facilitates the diagnosis of autoimmune hepatitis.
Hepatology
; 75(1): 13-27, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34473365
13.
Liver injury after SARS-CoV-2 vaccination: Features of immune-mediated hepatitis, role of corticosteroid therapy and outcome.
Hepatology
; 76(6): 1576-1586, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35567545
14.
Interferon gamma-induced protein 10 (IP-10) for the early prognosis of the risk for severe respiratory failure and death in COVID-19 pneumonia.
Cytokine
; 162: 156111, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36529030
15.
Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one-year non-responders and predicts survival.
Liver Int
; 43(7): 1497-1506, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37157905
16.
HERACLIS-HDV cohort for the factors of underdiagnosis and prevalence of hepatitis D virus infection in HBsAg-positive patients.
Liver Int
; 43(9): 1879-1889, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37288712
17.
Impact on follow-up strategies in patients with primary sclerosing cholangitis.
Liver Int
; 43(1): 127-138, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35535655
18.
Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group.
J Hepatol
; 76(4): 841-849, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35066089
19.
Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on HBV genotype and viral antigen levels.
J Hepatol
; 76(5): 1042-1050, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35092743
20.
An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B.
J Hepatol
; 76(2): 311-318, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34606915